Robert Kramer, Emergent BioSolutions CEO
Emergent scores a DoD award to evaluate its chikungunya vaccine in the field
Emergent BioSolutions is looking to make progress with its chikungunya vaccine and has received a $10 million US government grant to help it along. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.